Cronos Group Inc. Files Q2 2024 10-Q Report
Ticker: CRON · Form: 10-Q · Filed: 2024-08-08T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, earnings, cannabis
TL;DR
**CRONOS GROUP Q2 24 10-Q FILED - FINANCIALS OUT**
AI Summary
Cronos Group Inc. filed its 10-Q for the period ending June 30, 2024. The filing covers the second quarter of 2024 and provides financial details for the company. Specific financial figures and operational updates are detailed within the report.
Why It Matters
This filing provides investors and analysts with the latest financial performance and operational status of Cronos Group Inc., crucial for understanding the company's trajectory in the cannabis industry.
Risk Assessment
Risk Level: medium — The cannabis industry is subject to significant regulatory, market, and operational risks, which are inherent in this type of filing.
Key Numbers
- 2024 Q2 — Reporting Period (Covers the second quarter of 2024 financial performance.)
- 2023-12-31 — Prior Year End (Reference point for year-over-year comparisons.)
- 2023-06-30 — Prior Year Q2 (Reference point for year-over-year Q2 comparisons.)
Key Players & Entities
- Cronos Group Inc. (company) — Filer of the 10-Q report
- 20240630 (date) — End of the reporting period
- 20240808 (date) — Filing date of the report
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is June 30, 2024.
When was this 10-Q report filed with the SEC?
This 10-Q report was filed on August 8, 2024.
What was the previous company name for Cronos Group Inc.?
The former company name for Cronos Group Inc. was PharmaCan Capital Corp.
What is the fiscal year end for Cronos Group Inc.?
The fiscal year end for Cronos Group Inc. is December 31.
What is the SIC code for Cronos Group Inc.?
The Standard Industrial Classification (SIC) code for Cronos Group Inc. is 2833, which corresponds to MEDICINAL CHEMICALS & BOTANICAL PRODUCTS.
From the Filing
0001656472-24-000089.txt : 20240808 0001656472-24-000089.hdr.sgml : 20240808 20240808073254 ACCESSION NUMBER: 0001656472-24-000089 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 80 CONFORMED PERIOD OF REPORT: 20240630 FILED AS OF DATE: 20240808 DATE AS OF CHANGE: 20240808 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cronos Group Inc. CENTRAL INDEX KEY: 0001656472 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-38403 FILM NUMBER: 241186075 BUSINESS ADDRESS: STREET 1: 4491 CONCESSION RD 12 CITY: STAYNER STATE: A6 ZIP: L0M 1S0 BUSINESS PHONE: (416) 504-0004 MAIL ADDRESS: STREET 1: 6D - 7398 YONGE ST STREET 2: PMB 732 CITY: THORNHILL STATE: A6 ZIP: L4J 8J2 FORMER COMPANY: FORMER CONFORMED NAME: PharmaCan Capital Corp. DATE OF NAME CHANGE: 20151021 10-Q 1 cron-20240630.htm 10-Q cron-20240630 false 2024 Q2 0001656472 --12-31 00-0000000 P3Y P3Y P3Y xbrli:shares iso4217:USD iso4217:USD xbrli:shares cron:segment xbrli:pure iso4217:CAD iso4217:ILS iso4217:CAD xbrli:shares cron:shareholder cron:complaint cron:defendant 0001656472 2024-01-01 2024-06-30 0001656472 2024-08-05 0001656472 2024-06-30 0001656472 2023-12-31 0001656472 2024-04-01 2024-06-30 0001656472 2023-04-01 2023-06-30 0001656472 2023-01-01 2023-06-30 0001656472 us-gaap:CommonStockMember 2023-12-31 0001656472 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001656472 us-gaap:RetainedEarningsMember 2023-12-31 0001656472 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001656472 us-gaap:NoncontrollingInterestMember 2023-12-31 0001656472 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001656472 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001656472 2024-01-01 2024-03-31 0001656472 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001656472 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-03-31 0001656472 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001656472 us-gaap:CommonStockMember 2024-03-31 0001656472 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001656472 us-gaap:RetainedEarningsMember 2024-03-31 0001656472 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001656472 us-gaap:NoncontrollingInterestMember 2024-03-31 0001656472 2024-03-31 0001656472 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001656472 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001656472 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001656472 us-gaap:NoncontrollingInterestMember 2024-04-01 2024-06-30 0001656472 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0001656472 us-gaap:CommonStockMember 2024-06-30 0001656472 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001656472 us-gaap:RetainedEarningsMember 2024-06-30 0001656472 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001656472 us-gaap:NoncontrollingInterestMember 2024-06-30 0001656472 us-gaap:CommonStockMember 2022-12-31 0001656472 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001656472 us-gaap:RetainedEarningsMember 2022-12-31 0001656472 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001656472 us-gaap:NoncontrollingInterestMember 2022-12-31 0001656472 2022-12-31 0001656472 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001656472 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001656472 2023-01-01 2023-03-31 0001656472 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001656472 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0001656472 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001656472 us-gaap:CommonStockMember 2023-03-31 0001656472 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001656472 us-gaap:RetainedEarningsMember 2023-03-31 0001656472 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 00016